PSNL and TEM Related Headlines
Go Back- Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction'
- PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
- Needham Downgrades Personalis (PSNL) to Hold
- Tempus AI to acquire Personalis in $1.5B stock deal
- Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
PSNL and TEM Related Press Releases
Go Back- PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
- Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
